Evidence map›Paper›PMID 17922029›Full record

ArticleOncogene2008

Complex patterns of ETS gene alteration arise during cancer development in the human prostate.

J Clark, G Attard, S Jhavar, P Flohr, A Reid, J De-Bono, R Eeles, P Scardino, J Cuzick, G Fisher and 5 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03912883 (Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting), which is not on this map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03912883 active not recruitingnot on this map

Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting

TypeobservationalSponsorQueen Mary University of LondonRan1999 to 2030Enrolled3,350ConditionsProstate Cancer
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 149 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Androgen-Driven Fusion Genes and Chimeric Transcripts in Prostate Cancer.Frontiers in cell and developmental biology · 2021
    Review
  11. Article
  12. Article
  13. The Genomics of Prostate Cancer: A Historic Perspective.Cold Spring Harbor perspectives in medicine · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

J ClarkInstitute of Cancer Research, Male Urological Cancer Research Centre, Sutton, Surrey, UK. jeremy.clark@icr.ac.uk
G Attard
S Jhavar
P Flohr
A Reid
J De-Bono
R Eeles
P Scardino
J Cuzick
G Fisher
M D Parker
C S Foster
D Berney
G Kovacs
C S Cooper
Institute of Cancer Research · GBUniversity of London · GBHeidelberg University · DEMemorial Sloan Kettering Cancer Center · USRoyal Marsden NHS Foundation Trust · GBSt Bartholomew's Hospital · GBUniversity of Liverpool · GB

Funding

Cancer Research UKMedical Research Council G0501019
6 · The paper itself

Abstract

An ERG gene 'break-apart' fluorescence in situ hybridization (FISH) assay has been used to screen whole-mount prostatectomy specimens for rearrangements at the ERG locus. In cancers containing ERG alterations the observed pattern of changes was often complex. Different categories of ERG gene alteration were found either together in a single cancerous region or within separate foci of cancer in the same prostate slice. In some cases the juxtaposition of particular patterns of ERG alterations suggested possible mechanisms of tumour progression. Prostates harbouring ERG alterations commonly also contained cancer that lacked rearrangements of the ERG gene. A single trans-urethral resection of the prostate specimen examined harboured both ERG and ETV1 gene rearrangements demonstrating that the observed complexity may, at least in part, be explained by multiple ETS gene alterations arising independently in a single prostate. In a search for possible precursor lesions clonal ERG rearrangements were found both in high grade prostatic intraepithelial neoplasia (PIN) and in atypical in situ epithelial lesions consistent with the diagnosis of low grade PIN. Our observations support the view that ERG gene alterations represent an initiating event that promotes clonal expansion initially to form regions of epithelial atypia. The complex patterns of ERG alteration found in prostatectomy specimens have important implications for the design of experiments investigating the clinical significance and mechanism of development of individual prostate cancers.

Indexed as

Chromosome AberrationsAdultAgedDNA-Binding ProteinsHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedPrecancerous ConditionsProstatic Intraepithelial NeoplasiaProstatic NeoplasmsProto-Oncogene Proteins c-etsSerine EndopeptidasesTissue Array AnalysisTrans-ActivatorsTranscriptional Regulator ERGDNA-Binding ProteinsERG protein, humanProto-Oncogene Proteins c-etsSerine EndopeptidasesTMPRSS2 protein, humanTrans-ActivatorsTranscriptional Regulator ERG

Identifiers

PMID17922029
OpenAlexW1964252337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.